Cervical dystonia: clinical and therapeutic features in 85 patients Distonia cervical: aspectos clínicos e terapêuticos de 85 pacientes [PDF]
Arquivos de Neuro-Psiquiatria, 2008 We studied patients with cervical dystonia (CD) to determine clinical features and response to botulinum toxin A (BoNT/A). Patients were submitted to clinical, laboratory and neuroimaging evaluation.
Carlos Henrique F. Camargo +5 more
doaj +3 more sources
Perfil funcional de pacientes com distonia cervical: uma série de casos [PDF]
Revista Pesquisa em Fisioterapia, 2018 INTRODUÇÃO: A Distonia Cervical (DC) é uma doença dos núcleos da base e tem como consequência movimentos hipercinéticos, sendo a mais comum entre as distonias focais.
Carolina Cerqueira Santos +1 more
doaj +4 more sources
Head tremor in patients with cervical dystonia: different outcome? Tremor cefálico em pacientes com distonia cervical: evolução diferente? [PDF]
Arquivos de Neuro-Psiquiatria, 2008 OBJECTIVE: The association of cervical dystonia (CD) with other movement disorders have been already described, but data on clinical outcome regarding these patients are scant.
Clecio Godeiro-Junior +5 more
doaj +5 more sources
Toxina botulínica no blefaroespasmo, no espasmo hemifacial e na distonia cervical: resultados em 33 pacientes Botulinum toxin in blepharospasm, hemifacial spasm and cervical dystonia: results in 33 patients [PDF]
Arquivos de Neuro-Psiquiatria, 1995 Avaliamos os resultados terapêuticos obtidos com o emprego de toxina botulínica do tipo A em 33 pacientes com distonia (12 com blefaroespamo; 10 com espasmo hemifacial e 11 com torcicolo espasmódico). Utilizamos uma escala de pontuação de gravidade antes
Sérgio Ap. Novis +2 more
doaj +7 more sources
Nueva mutación en el gen KMT2B como causa de distonía generalizada de inicio temprano: reporte de caso [PDF]
Biomédica: revista del Instituto Nacional de Salud, 2022 La distonía por mutación en el gen KMT2B es un subtipo recientemente descrito del inicio focal de la enfermedad en los miembros inferiores que, posteriormente, evoluciona a una forma generalizada con compromiso cervical y orofaríngeo, disartria ...
Yully Andrea Rangel, Eugenia Espinosa
doaj +2 more sources
Quality of life at cervical distonia
Бюллетень сибирской медицины, 2020 The aim of the study was to study the physical and psychological components regarding the quality of life of patients with cervical dystonia.Material and methods. 170 respondents were examined. The main group included 120 patients with cervical dystonia,
O. A. Druzhinina +2 more
doaj +3 more sources
Retrocollis, anterocollis or head tremor may predict the spreading of dystonic movements in primary cervical dystonia Retrocolis, anterocolis ou tremor cefálico podem predizer a progressão dos movimentos distônicos em pacientes com distonia cervical primária [PDF]
Arquivos de Neuro-Psiquiatria, 2009 BACKGROUND AND PURPOSE: Few studies have attempted to develop clinical predictors for cervical dystonia (CD) aiming at progression of the dystonic movement.
Clecio Godeiro-Junior +5 more
doaj +4 more sources
Cross-cultural adaptation of the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) to Brazilian Portuguese [PDF]
Arquivos de Neuro-Psiquiatria, 2011 Cervical dystonia (CD) is a prevalent and incapacitating movement disorder which needs a thorough clinical evaluation of every patient to better tailor treatment strategies. In Brazil, there are no validated CD scales that measure the burden of dystonia.
F A Sekeff-Sallem +2 more
doaj +4 more sources
Percheron thalamopeduncular syndrome with cervical dystonia: A case report [PDF]
Dementia & Neuropsychologia, 2016 Bilateral thalamic infarctions are usually caused by occlusion of the "Artery of Percheron" (AoP). Thalamopeduncular syndrome is among the most common presentations of AoP occlusion.
Luiz Felipe Vasconcellos +4 more
doaj +2 more sources
Experiência com aplicação de toxina botulínica A em 115 pacientes Botulinum toxin A: experience in the treatment of 115 patients [PDF]
Arquivos de Neuro-Psiquiatria, 1997 A toxina botulínica A é a forma mais eficaz de tratar algumas distonias focais e o espasmo hemifacial. Devido a seu custo ainda elevado no nosso país, seu uso ainda não é disseminado. Mostramos nossa experiência com a toxina botulínica A em 115 pacientes,
Luiz Augusto F. Andrade +3 more
doaj +4 more sources